| abstract |
Disclosed is a pharmaceutical comprising a novel compound as an active ingredient, which exhibits strong antibacterial activity against Gram-negative bacteria such as Pseudomonas aeruginosa and drug-resistant bacteria based on LpxC inhibitory action. SOLUTION: General formula A prophylactic or therapeutic agent for infectious diseases caused by gram-negative bacteria containing a hydroxamic acid derivative represented by the formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient. [Selection figure] None |